Steve Abrams > Hogan Lovells US LLP > Philadelphia, United States > Lawyer Profile

Hogan Lovells US LLP
United States

Work Department

Corporate and Finance


Global Co-Head of Life Sciences & Health Care industry sector group


As Global Co-Head of Hogan Lovells’ Life Sciences & Health Care industry sector, Steve Abrams works with clients in many areas of the life sciences ecosystem, such as oncology therapies, pain products, dermatology therapies, vaccines, diagnostics, medical devices and drug/device combinations, orphan drugs, and gene therapies. He also counsels a variety of companies that provide services to the life sciences industry.

Steve has successfully negotiated and completed a range of life sciences transactions, with a particular focus on capital market offerings (IPOs, follow-on offerings, ATMs, RDOs, PIPES, and private placements), collaboration/licensing transactions, and M&A transactions. Additionally, he regularly advises public and privately held clients, including boards of directors, on securities, governance, transactional, and a range of other complex issues.

Steve is a member of the board of directors of inTEST Corporation (NASDAQ: INTT), and a member of its Audit and Compensation Committees. He is Chair of its Nominating Committee as well.  Steve has lectured in front of various groups and published articles on securities, governance, and M&A issues.




J.D., University of Pennsylvania Law School, cum laude, 1995

B.A., Rutgers University, summa cum laude, 1990

Lawyer Rankings

United States > Finance > Capital markets: equity offerings

Hogan Lovells US LLP has made big progress in the equity sphere since the arrival of Richard Aftanas in 2020. Aftanas has given the firm much greater credibility in New York, an office that had been comparatively underweight compared to the firm’s other US offices. Historically the capital markets team has shown particular aptitude in the real estate, life sciences, healthcare and TMT fields, and now is spreading its industry breadth along with particular growth in cross-border offerings originating from Europe, Latin America and elsewhere. The team also benefits from the firm’s outstanding regulatory expertise. Philadelphia partner Steve Abrams co-heads the life sciences and healthcare group and has a fine record in equity offerings, while Washington DC’s David Bonser leads the global REIT practice and heads numerous equity issuances in this field.

United States > Industry focus > Healthcare: life sciences

In addition to ‘outstanding expertise with small to mid-sized public biotech and pharma companies’ Hogan Lovells US LLP is also able to act for international pharmaceuticals companies. The team’s regulatory capacity is a key factor in this, advising on FDA clearances and post-approval compliance. IP is another area of expertise, primarily in transactions where the team provides diligence support in major capital markets and M&A matters and acts on IP litigation. It also has a strong product liability offering led by Baltimore-based Lauren Colton, which advises on medical devices and pharmaceuticals. The Washington DC office is led by biologics risk evaluation expert Lynn Mehler, experienced biopharmaceutical startup advisor Philip Katz and Randy Prebula, who gives regulatory advice to medical device and technology companies. Also DC-based is David Fox, who is known for his Hatch Waxman compliance expertise. Philadelphia-based team leader Steve Abrams is known for transactional work. Also recommended are DC-based Anishiya Abrol and Philadephia-based Blake Wilson.